Meet Our Semi-Finalist - Chimera Bioengineering

Chimera Bioengineering is a semi-finalist of the 2021 BRACE Award Venture Competition. Learn more about their innovative oncology technology that has the potential to save lives.

The Asian Fund for Cancer Research (AFCR) is proud to present the BRACE Award, Bridging Research from Academia to Cancer Entrepreneurship. The program is designed to advance and catalyze the commercialization of innovative cancer research discoveries.

The winning business will receive the equivalent of US$300,000 in investment funding from AFCR, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.